Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from Bordetella pertussis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from Bordetella pertussis
Authors
Keywords
-
Journal
npj Vaccines
Volume 4, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-10-03
DOI
10.1038/s41541-019-0136-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunization with whole cell but not acellular pertussis vaccines primes CD4 TRM cells that sustain protective immunity against nasal colonization with Bordetella pertussis
- (2019) Mieszko M. Wilk et al. Emerging Microbes & Infections
- A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against Bordetella pertussis, Including Pertactin Deficient Strains
- (2019) María Eugenia Zurita et al. Frontiers in Cellular and Infection Microbiology
- Pertussis vaccines and protective immunity
- (2019) Parul Kapil et al. CURRENT OPINION IN IMMUNOLOGY
- Maternal Vaccination With a Monocomponent Pertussis Toxoid Vaccine Is Sufficient to Protect Infants in a Baboon Model of Whooping Cough
- (2018) Parul Kapil et al. JOURNAL OF INFECTIOUS DISEASES
- IL-17-dependent SIgA-mediated protection against nasal Bordetella pertussis infection by live attenuated BPZE1 vaccine
- (2018) Luis Solans et al. Mucosal Immunology
- Sustained protective immunity against Bordetella pertussis nasal colonization by intranasal immunization with a vaccine-adjuvant combination that induces IL-17-secreting TRM cells
- (2018) Aideen C. Allen et al. Mucosal Immunology
- The pertussis hypothesis: Bordetella pertussis colonization in the pathogenesis of Alzheimer’s disease
- (2017) Keith Rubin et al. IMMUNOBIOLOGY
- Lung CD4 Tissue-Resident Memory T Cells Mediate Adaptive Immunity Induced by Previous Infection of Mice withBordetella pertussis
- (2017) Mieszko M. Wilk et al. JOURNAL OF IMMUNOLOGY
- Live Attenuated Pertussis Vaccine BPZE1 Protects Baboons Against Bordetella pertussis Disease and Infection
- (2017) Camille Locht et al. JOURNAL OF INFECTIOUS DISEASES
- IL-17–Producing Innate and Pathogen-Specific Tissue Resident Memory γδ T Cells Expand in the Lungs ofBordetella pertussis–Infected Mice
- (2016) Alicja Misiak et al. JOURNAL OF IMMUNOLOGY
- Waning Tdap Effectiveness in Adolescents
- (2016) Nicola P. Klein et al. PEDIATRICS
- Asymptomatic transmission and the resurgence of Bordetella pertussis
- (2015) Benjamin M. Althouse et al. BMC Medicine
- Roads to the development of improved pertussis vaccines paved by immunology
- (2015) Jolanda Brummelman et al. Pathogens and Disease
- Contribution of pertussis toxin to the pathogenesis of pertussis disease: Graphical Abstract Figure.
- (2015) Nicholas H. Carbonetti Pathogens and Disease
- Pertactin-Negative Bordetella pertussis Strains: Evidence for a Possible Selective Advantage
- (2014) S. W. Martin et al. CLINICAL INFECTIOUS DISEASES
- Bordetella pertussis pathogenesis: current and future challenges
- (2014) Jeffrey A. Melvin et al. NATURE REVIEWS MICROBIOLOGY
- A Phase I Clinical Study of a Live Attenuated Bordetella pertussis Vaccine - BPZE1; A Single Centre, Double-Blind, Placebo-Controlled, Dose-Escalating Study of BPZE1 Given Intranasally to Healthy Adult Male Volunteers
- (2014) Rigmor Thorstensson et al. PLoS One
- Comparative Effectiveness of Acellular Versus Whole-Cell Pertussis Vaccines in Teenagers
- (2013) N. P. Klein et al. PEDIATRICS
- Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults—A review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience
- (2013) Birgit Thierry-Carstensen et al. VACCINE
- Relative Contribution of Th1 and Th17 Cells in Adaptive Immunity to Bordetella pertussis: Towards the Rational Design of an Improved Acellular Pertussis Vaccine
- (2013) Pádraig J. Ross et al. PLoS Pathogens
- Th17-stimulating Protein Vaccines Confer Protection againstPseudomonas aeruginosaPneumonia
- (2012) Weihui Wu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Immunity to the respiratory pathogen Bordetella pertussis
- (2012) R Higgs et al. Mucosal Immunology
- Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children
- (2012) Nicola P. Klein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Decreased Leukocyte Accumulation and Delayed Bordetella pertussis Clearance in IL-6-/- Mice
- (2011) X. Zhang et al. JOURNAL OF IMMUNOLOGY
- A Live, AttenuatedBordetella pertussisVaccine Provides Long-Term Protection against Virulent Challenge in a Murine Model
- (2010) Ciaran M. Skerry et al. Clinical and Vaccine Immunology
- Pertussis toxin and adenylate cyclase toxin: key virulence factors ofBordetella pertussisand cell biology tools
- (2010) Nicholas H Carbonetti Future Microbiology
- Human Dendritic Cells Activated via Dectin-1 Are Efficient at Priming Th17, Cytotoxic CD8 T and B Cell Responses
- (2010) Sudhanshu Agrawal et al. PLoS One
- Curdlan Induces DC-Mediated Th17 Polarization via Jagged1 Activation in Human Dendritic Cells
- (2010) Takehiro Higashi et al. ALLERGOLOGY INTERNATIONAL
- β-glucan recognition by the innate immune system
- (2009) Helen S. Goodridge et al. IMMUNOLOGICAL REVIEWS
- Involvement of the NLRP3 Inflammasome in Innate and Humoral Adaptive Immune Responses to Fungal -Glucan
- (2009) H. Kumar et al. JOURNAL OF IMMUNOLOGY
- Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-κB activation through Raf-1 and Syk
- (2009) Sonja I Gringhuis et al. NATURE IMMUNOLOGY
- Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
- (2008) Stephanie C. Eisenbarth et al. NATURE
- The Extracytoplasmic Stress Factor, σE, Is Required to Maintain Cell Envelope Integrity in Escherichia coli
- (2008) Jennifer D. Hayden et al. PLoS One
- In vitro self-assembly of tailorable nanotubes from a simple protein building block
- (2008) E. R. Ballister et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of a freeze-stable formulation for vaccines containing aluminum salt adjuvants
- (2008) LaToya Jones Braun et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More